Literature DB >> 22412741

Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetra-hydro-isoquinoline-4-carboxyl-ate.

Xing-Yao Li1, Jin-Long Wu.   

Abstract

In the title compound, C(13)H(13)NO(4), the fused-ring system is nearly planar, with an r.m.s. deviation of 0.0408 Å. In the crystal, mol-ecules are linked into centrosymmetric dimers by a pair of N-H⋯O hydrogen bonds. The ethyl group is disordered over two positions in a ratio of 0.758 (6):0.242 (6).

Entities:  

Year:  2012        PMID: 22412741      PMCID: PMC3297938          DOI: 10.1107/S1600536812008136

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For pharmaceutical usage of derivatives of isoquinoline-1,3(2H,4H)-dione, see: Lu et al. (2010 ▶); Tsou et al. (2008 ▶, 2009 ▶); Billamboz et al. (2011 ▶).

Experimental

Crystal data

C13H13NO4 M = 247.24 Triclinic, a = 6.4585 (9) Å b = 8.1999 (7) Å c = 12.5763 (11) Å α = 78.876 (7)° β = 77.228 (9)° γ = 72.354 (9)° V = 613.28 (11) Å3 Z = 2 Mo Kα radiation μ = 0.10 mm−1 T = 293 K 0.38 × 0.23 × 0.09 mm

Data collection

Agilent Xcalibur Atlas Gemini ultra diffractometer Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2010 ▶) T min = 0.963, T max = 0.991 3820 measured reflections 2243 independent reflections 1659 reflections with I > 2σ(I) R int = 0.021

Refinement

R[F 2 > 2σ(F 2)] = 0.049 wR(F 2) = 0.135 S = 1.06 2243 reflections 170 parameters 5 restraints H-atom parameters constrained Δρmax = 0.18 e Å−3 Δρmin = −0.25 e Å−3 Data collection: CrysAlis PRO (Agilent, 2010 ▶); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: OLEX2 (Dolomanov et al., 2009 ▶); software used to prepare material for publication: OLEX2. Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536812008136/xu5472sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536812008136/xu5472Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536812008136/xu5472Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C13H13NO4Z = 2
Mr = 247.24F(000) = 260
Triclinic, P1Dx = 1.339 Mg m3
Hall symbol: -P 1Mo Kα radiation, λ = 0.71073 Å
a = 6.4585 (9) ÅCell parameters from 1387 reflections
b = 8.1999 (7) Åθ = 3.3–29.2°
c = 12.5763 (11) ŵ = 0.10 mm1
α = 78.876 (7)°T = 293 K
β = 77.228 (9)°Platelet, colorless
γ = 72.354 (9)°0.38 × 0.23 × 0.09 mm
V = 613.28 (11) Å3
Agilent Xcalibur Atlas Gemini ultra diffractometer2243 independent reflections
Radiation source: fine-focus sealed tube1659 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.021
Detector resolution: 10.3592 pixels mm-1θmax = 25.4°, θmin = 3.3°
ω scansh = −7→6
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2010)k = −9→9
Tmin = 0.963, Tmax = 0.991l = −14→15
3820 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.049Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.135H-atom parameters constrained
S = 1.06w = 1/[σ2(Fo2) + (0.061P)2 + 0.1013P] where P = (Fo2 + 2Fc2)/3
2243 reflections(Δ/σ)max < 0.001
170 parametersΔρmax = 0.18 e Å3
5 restraintsΔρmin = −0.25 e Å3
Experimental. 1H NMR (400 MHz, CDCl3): 8.37 (br s, 1H), 8.26 (d, J = 8.0 Hz, 1H), 7.68 (t, J = 8.0 Hz, 1H), 7.52 (t, J = 8.0 Hz, 1H), 7.41 (d, J = 7.6 Hz, 1H), 4.23-4.05 (m, 2H), 1.89 (s, 3H), 1.12 (t, J = 7.2 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3): 171.1, 169.1, 163.6, 140.1, 134.8, 128.9, 128.6, 125.9, 123.5, 62.6, 55.0, 25.1, 13.7 ppm.
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/UeqOcc. (<1)
O10.2337 (3)−0.13049 (17)0.54786 (12)0.0529 (4)
O2−0.1215 (2)0.40108 (18)0.63638 (13)0.0527 (4)
O30.1682 (3)0.4585 (2)0.83716 (14)0.0734 (6)
O4−0.0080 (3)0.2543 (2)0.86413 (12)0.0610 (5)
N10.0689 (3)0.13902 (19)0.58943 (13)0.0379 (4)
H1−0.02680.14710.54940.046*
C10.5645 (4)−0.1829 (3)0.67306 (17)0.0453 (5)
H1A0.5636−0.27590.64110.054*
C20.7280 (4)−0.1987 (3)0.7311 (2)0.0559 (6)
H20.8373−0.30230.73900.067*
C30.7288 (4)−0.0596 (3)0.7776 (2)0.0578 (6)
H30.8405−0.06960.81610.069*
C40.5663 (4)0.0937 (3)0.76769 (18)0.0477 (6)
H40.56840.18580.80010.057*
C50.3988 (3)0.1116 (2)0.70940 (15)0.0333 (4)
C60.4003 (3)−0.0284 (2)0.66182 (14)0.0333 (4)
C70.2317 (3)−0.0136 (2)0.59585 (15)0.0353 (5)
C80.0413 (3)0.2804 (2)0.63970 (15)0.0338 (4)
C90.2282 (3)0.2843 (2)0.69348 (14)0.0325 (4)
C100.3389 (4)0.4169 (3)0.61867 (18)0.0478 (5)
H10A0.45220.42980.65200.072*
H10B0.23070.52610.60880.072*
H10C0.40300.37760.54850.072*
C110.1267 (3)0.3452 (3)0.80564 (17)0.0420 (5)
C12−0.1109 (6)0.3031 (5)0.9735 (2)0.0928 (10)
H12A0.00090.27581.01940.111*0.758 (6)
H12B−0.17980.42660.96740.111*0.758 (6)
H12C−0.07980.20261.02860.111*0.242 (6)
H12D−0.04930.38880.98840.111*0.242 (6)
C13−0.2713 (9)0.2137 (8)1.0226 (3)0.1076 (18)0.758 (6)
H13A−0.38580.24550.97910.161*0.758 (6)
H13B−0.33340.24321.09540.161*0.758 (6)
H13C−0.20360.09151.02680.161*0.758 (6)
C13A−0.340 (2)0.371 (2)0.9802 (11)0.1076 (18)0.242 (6)
H13D−0.37220.48420.93890.161*0.242 (6)
H13E−0.40900.37741.05580.161*0.242 (6)
H13F−0.39690.29690.95040.161*0.242 (6)
U11U22U33U12U13U23
O10.0628 (10)0.0400 (8)0.0648 (10)−0.0090 (7)−0.0201 (8)−0.0254 (7)
O20.0404 (9)0.0454 (9)0.0740 (10)0.0051 (7)−0.0223 (7)−0.0247 (8)
O30.0921 (14)0.0731 (11)0.0728 (11)−0.0273 (10)−0.0124 (10)−0.0462 (10)
O40.0681 (11)0.0740 (11)0.0415 (8)−0.0234 (9)0.0101 (7)−0.0258 (8)
N10.0375 (10)0.0385 (9)0.0429 (9)−0.0059 (7)−0.0146 (7)−0.0159 (7)
C10.0484 (13)0.0332 (11)0.0496 (12)−0.0030 (9)−0.0069 (10)−0.0094 (9)
C20.0492 (14)0.0422 (12)0.0656 (15)0.0057 (10)−0.0151 (11)−0.0057 (11)
C30.0463 (14)0.0610 (15)0.0650 (15)−0.0035 (12)−0.0275 (11)−0.0035 (12)
C40.0460 (13)0.0464 (12)0.0569 (13)−0.0082 (10)−0.0224 (10)−0.0133 (10)
C50.0323 (10)0.0331 (10)0.0342 (10)−0.0069 (8)−0.0043 (8)−0.0089 (8)
C60.0351 (11)0.0307 (10)0.0323 (10)−0.0078 (8)−0.0024 (8)−0.0062 (8)
C70.0385 (11)0.0320 (10)0.0371 (10)−0.0104 (9)−0.0027 (8)−0.0114 (8)
C80.0323 (11)0.0333 (10)0.0367 (10)−0.0072 (8)−0.0050 (8)−0.0112 (8)
C90.0329 (10)0.0293 (9)0.0380 (10)−0.0073 (8)−0.0070 (8)−0.0116 (8)
C100.0494 (13)0.0361 (11)0.0607 (13)−0.0152 (10)−0.0107 (10)−0.0058 (10)
C110.0405 (12)0.0409 (11)0.0459 (12)−0.0019 (10)−0.0133 (9)−0.0168 (10)
C120.094 (2)0.134 (3)0.0461 (15)−0.029 (2)0.0168 (14)−0.0391 (17)
C130.125 (4)0.143 (5)0.059 (3)−0.068 (4)0.035 (2)−0.030 (3)
C13A0.125 (4)0.143 (5)0.059 (3)−0.068 (4)0.035 (2)−0.030 (3)
O1—C71.223 (2)C6—C71.473 (3)
O2—C81.208 (2)C8—C91.519 (3)
O3—C111.197 (2)C9—C111.527 (3)
O4—C111.324 (3)C9—C101.535 (3)
O4—C121.463 (3)C10—H10A0.9600
N1—C71.371 (2)C10—H10B0.9600
N1—C81.372 (2)C10—H10C0.9600
N1—H10.8600C12—C13A1.406 (13)
C1—C21.373 (3)C12—C131.412 (5)
C1—C61.390 (3)C12—H12A0.9700
C1—H1A0.9300C12—H12B0.9700
C2—C31.380 (3)C12—H12C0.9700
C2—H20.9300C12—H12D0.9700
C3—C41.376 (3)C13—H13A0.9600
C3—H30.9300C13—H13B0.9600
C4—C51.394 (3)C13—H13C0.9600
C4—H40.9300C13A—H13D0.9600
C5—C61.390 (2)C13A—H13E0.9600
C5—C91.517 (2)C13A—H13F0.9600
C11—O4—C12115.2 (2)C9—C10—H10C109.5
C7—N1—C8127.34 (15)H10A—C10—H10C109.5
C7—N1—H1116.3H10B—C10—H10C109.5
C8—N1—H1116.3O3—C11—O4124.5 (2)
C2—C1—C6120.26 (19)O3—C11—C9123.9 (2)
C2—C1—H1A119.9O4—C11—C9111.54 (16)
C6—C1—H1A119.9C13A—C12—C1354.0 (7)
C1—C2—C3119.5 (2)C13A—C12—O4110.5 (6)
C1—C2—H2120.3C13—C12—O4110.2 (3)
C3—C2—H2120.3C13A—C12—H12A139.8
C4—C3—C2120.8 (2)C13—C12—H12A109.6
C4—C3—H3119.6O4—C12—H12A109.6
C2—C3—H3119.6C13A—C12—H12B58.6
C3—C4—C5120.40 (19)C13—C12—H12B109.6
C3—C4—H4119.8O4—C12—H12B109.6
C5—C4—H4119.8H12A—C12—H12B108.1
C6—C5—C4118.45 (18)C13A—C12—H12C109.5
C6—C5—C9121.52 (16)C13—C12—H12C58.8
C4—C5—C9119.93 (16)O4—C12—H12C109.5
C1—C6—C5120.58 (18)H12A—C12—H12C54.2
C1—C6—C7118.94 (17)H12B—C12—H12C140.7
C5—C6—C7120.46 (16)C13A—C12—H12D109.5
O1—C7—N1120.24 (17)C13—C12—H12D140.2
O1—C7—C6122.58 (17)O4—C12—H12D109.5
N1—C7—C6117.17 (15)H12A—C12—H12D56.7
O2—C8—N1120.90 (17)H12B—C12—H12D54.3
O2—C8—C9121.31 (15)H12C—C12—H12D108.1
N1—C8—C9117.70 (15)C12—C13—H13A109.5
C5—C9—C8114.29 (15)C12—C13—H13B109.5
C5—C9—C11108.88 (15)C12—C13—H13C109.5
C8—C9—C11107.75 (15)C12—C13A—H13D109.5
C5—C9—C10109.59 (16)C12—C13A—H13E109.5
C8—C9—C10106.40 (15)H13D—C13A—H13E109.5
C11—C9—C10109.85 (16)C12—C13A—H13F109.5
C9—C10—H10A109.5H13D—C13A—H13F109.5
C9—C10—H10B109.5H13E—C13A—H13F109.5
H10A—C10—H10B109.5
D—H···AD—HH···AD···AD—H···A
N1—H1···O1i0.862.052.903 (3)172
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N1—H1⋯O1i0.862.052.903 (3)172

Symmetry code: (i) .

  5 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function.

Authors:  Muriel Billamboz; Fabrice Bailly; Cédric Lion; Nadia Touati; Hervé Vezin; Christina Calmels; Marie-Line Andréola; Frauke Christ; Zeger Debyser; Philippe Cotelle
Journal:  J Med Chem       Date:  2011-03-02       Impact factor: 7.446

3.  4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4).

Authors:  Hwei-Ru Tsou; Mercy Otteng; Tritin Tran; M Brawner Floyd; Marvin Reich; Gary Birnberg; Kristina Kutterer; Semiramis Ayral-Kaloustian; Malini Ravi; Ramaswamy Nilakantan; Mary Grillo; John P McGinnis; Sridhar K Rabindran
Journal:  J Med Chem       Date:  2008-06-26       Impact factor: 7.446

4.  Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.

Authors:  Hwei-Ru Tsou; Xiaoxiang Liu; Gary Birnberg; Joshua Kaplan; Mercy Otteng; Tritin Tran; Kristina Kutterer; Zhilian Tang; Ron Suayan; Arie Zask; Malini Ravi; Angela Bretz; Mary Grillo; John P McGinnis; Sridhar K Rabindran; Semiramis Ayral-Kaloustian; Tarek S Mansour
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

5.  Molecular-docking-guided 3D-QSAR studies of substituted isoquinoline-1,3-(2H,4H)-diones as cyclin-dependent kinase 4 (CDK4) inhibitors.

Authors:  Xiao-Yun Lu; Ya-Dong Chen; Ni-yue Sun; Yong-Jun Jiang; Qi-Dong You
Journal:  J Mol Model       Date:  2009-06-20       Impact factor: 1.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.